Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Shanhai Group is a diversified healthcare conglomerate based in Shanghai, primarily operating within the 'Great Health' sector. The company's business model integrates health management, elderly care services, and biotechnology research, with a specific focus on cell storage and regenerative medicine through its subsidiary, Shanhai Biotechnology. It also engages in the distribution of medical devices and the development of health-focused tourism and real estate projects. The group aims to provide a comprehensive ecosystem for the aging population, combining traditional care with modern medical technology. While it has established a significant presence in the Chinese wellness market, the company has recently faced regulatory scrutiny regarding its financial operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Shanhai Group.